Udayavni Special

New drug combination found effective against coronavirus infection: Study


PTI, Oct 1, 2021, 12:20 PM IST

London:  A new drug combination can suppress infection by the SARS-CoV-2 virus, which causes COVID-19, according to a study conducted in animals and cell cultures.
Early test results, published in the journal Viruses, found that the combined use of the antiviral drugs nafamostat and Pegasys meets all availability and efficacy requirements.

“This combination effectively suppresses the infection,” said Denis Kainov, a professor at the Norwegian University of Science and Technology (NTNU).

The experiments were performed in cell cultures and hamsters, the researchers said.

They noted that this does not necessarily mean that the combination works in humans, but could be a hot tip for researchers who are already testing nafamostat in the fight against COVID-19.

According to the researchers nafamostat is already in use as a monotherapy against COVID-19 and is undergoing extensive testing in Japan, among other places.

Pegasys is currently used mainly to treat hepatitis C. Combining the two appears to have a positive effect, they said.

“Both drugs attack a factor in our cells called TMPRSS2, which plays a critical role in viral replication,” said Magnar Bjoras, a professor at NTNU.

The researchers noted that only low doses of combination medicine are needed.

“The low doses of the drugs in combination may have several clinical advantages. including fewer adverse events and improved outcomes for patients,” said Aleksandr Ianevski, a doctoral research fellow at NTNU.

The researchers believe the combination medicine can both save lives and make life easier for patients.

Nafamostat is relatively inexpensive while the downside of Pegasys is its higher cost, they noted.

“SARS-CoV-2 and its vaccine/immune-escaping variants continue to pose a serious threat to public health due to a paucity of effective, rapidly deployable, and widely available treatments,” the authors of the study noted.

“Our study may provide a proactive solution for the ongoing pandemic and potential future coronavirus outbreaks, which is still urgently required in many parts of the world,” they added.

Apart from NTNU, other researchers in the study are from Oslo University Hospital, the University of Oslo, both in Norway, the French precision medicine company Oncodesign, the University of Tartu in Estonia and the University of Helsinki in Finland.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

BSF opens fire at drone along Indo-Pak border in Punjab’s Amritsar sector

Any person from outside Gandhi family should become next Cong chief, not Rahul Gandhi: Athawale

Maha Terror case: SC says ATS not barred from investigation till NIA took over probe

India-Lanka ties getting stronger and stronger: PM Modi

Yediyurappa asks Nalin Kumar Kateel to not make disparaging remarks against Rahul Gandhi

Karnataka bans celebrity birthday parties at child care homes

Taliban behead woman athlete who was part of Afghan junior women’s national volleyball team

Related Articles More

COVID-19 and pregnancy: Women regret not getting the vaccine

New mutation AY.4.2 of Delta variant being monitored in England

Global Hunger Index 2021 reflects India’s reality where hunger accentuated post Covid: Oxfam

AstraZeneca joins hands with RGCI to treat leukaemia patients

Continued coordinated policy response to combat COVID-19 is critical to overcome health crisis: IMF

MUST WATCH

Air Layering Method – How It’s Made

News Bulletin 20-10-2021

Mysore Ambaari Bus Trip | Dasara 2021

Elephant Attack at Tibet Camp in Hunsuru

Pady Harvesting Mechine fare hike


Latest Additions

BSF opens fire at drone along Indo-Pak border in Punjab’s Amritsar sector

20 more acquitted in 2013 Muzaffarnagar riot case

Minor girl gang-raped in Kerala, four held

Any person from outside Gandhi family should become next Cong chief, not Rahul Gandhi: Athawale

Maha Terror case: SC says ATS not barred from investigation till NIA took over probe

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.